Several studies show that downregulation of DARC indicates poor prognosis of breast cancer, colorectal cancer, prostate cancer, cervical squamous cell cancer, thyroid cancer, and gastric cancer [6–10]. This evidence concerns the gene ACKR1 and breast carcinoma.